Nanomedicine and nanotoxicology: the pros and cons for neurodegeneration and brain cancer
J. Catalan-Figueroa1, S. Palma-Florez, G. Alvarez, H.F. Fritz, M.O. Jara, J.O. Morales2
J. Catalan-Figueroa1, S. Palma-Florez, G. Alvarez, H.F. Fritz, M.O. Jara, J.O. Morales2
Andrónico Neira-Carrilloa3, Edith Yslasa, Yazmin Amar Marinia, Patricio Vásquez-Quitral, Marianela Sánchez, Ana Riveros, Diego Yáñez, Pablo Cavallo, Marcelo J. Kogan, Diego Acevedo2
M. Montenegro-Nicolini1 and J.O. Morales2
Nataly Silva1, Camila Muñoz, Jordi Diaz-Marcos, Josep Samitier, Nicolás Yutronic, Marcelo J Kogan2, Paul Jara2
Riquelme I1, Ili C, Roa JC, Brebi P2
Koshiol J3, Castro F, Kemp TJ, Gao YT, Roa JC, Wang B, Nogueira L, Araya JC, Shen MC, Rashid A, Hsing AW, Hildesheim A, Ferreccio C, Pfeiffer RM, Pinto LA.